← Product Code [NHA](/submissions/DE/subpart-d%E2%80%94prosthetic-devices/NHA) · K080239 # P.004 ABUTMENTS, P.004 TEMPORARY COPINGS, P.004 PROTECTIVE CAPS, P.004 PERMANENT COPINGS (K080239) _Straumann Manufacturing, Inc. · NHA · Apr 30, 2008 · Dental · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/NHA/K080239 ## Device Facts - **Applicant:** Straumann Manufacturing, Inc. - **Product Code:** [NHA](/submissions/DE/subpart-d%E2%80%94prosthetic-devices/NHA.md) - **Decision Date:** Apr 30, 2008 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 872.3630 - **Device Class:** Class 2 - **Review Panel:** Dental - **Attributes:** Therapeutic ## Intended Use Abutments are placed into dental implants to provide support for prosthetic restorations such as crowns, bridges and overdentures, Abutments can be used in single tooth replacements and multiple tooth restorations. The subject abutments are for permanent screw-retained bridges and bar-retained implant-borne dentures. Permanent copings are intended to serve as a base for multi-unit bar or bridge restorations. Temporary Copings are intended to serve as a base for temporary restorations for up to 6 month. Protective Caps are intended to protect the outer configuration of the abutment and to maintain and condition the contours of the soft tissue during the healing phase for up to 6 months. ## Device Story Straumann P.004 Dental Implant System consists of endosseous dental implants, abutments, copings, and protective caps. Abutments connect to implants to support prosthetic restorations (crowns, bridges, overdentures). Temporary copings support temporary restorations; protective caps maintain soft tissue contours during healing. Used in dental clinics by dentists/specialists. System provides mechanical foundation for prosthetic reconstruction in edentulous patients; improves oral function and aesthetics. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Endosseous dental implant abutments, copings, and protective caps. Materials, design, and operating principles are identical to previously cleared Straumann devices. Mechanical components for dental restoration support. ## Regulatory Identification An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation. ## Special Controls *Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.) ## Predicate Devices - Straumann Octa Abutment ([K894844](/device/K894844.md)) - Straumann synOcta Abutment ([K994119](/device/K994119.md)) - Temporary Copings ([K894844](/device/K894844.md)) - ITI Protective Healing Caps ([K962023](/device/K962023.md)) - ITI Protective Healing Caps ([K051717](/device/K051717.md)) - RN synOcta Gold Copings for Bridges ([K022859](/device/K022859.md)) - RN synOcta Gold Copings for Bars ([K894844](/device/K894844.md)) - RN synOcta Titanium Copings for Bars ([K990342](/device/K990342.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K080239 # Section I 510(k) SUMMARY APR 3 0 2008 #### 1. Applicant's Name and Address Straumann US (on behalf of Institut Straumann AG) 60 Minuteman Rd. Andover, MA 01810 Telephone Number: 978-747-2513 Fax Number: 978-747-0023 Contact Person: Elaine Alan Regulatory Affairs Specialist Date of Submission: #### 2. Name of the Device Trade Name: Common Name: Classification Name: Regulation Number: P.004 RC/NC Bar and Bridge Abutments Line Abutment, Dental, Endosseous implants Abutment, Dental, Endosseous implants 21 CFR 872.3630 ### 3. Legally Marketed Device to which Equivalence is Claimed (Predicate Device) January 30, 2008 Straumann Octa Abutment, K894844 Straumann synOcta Abutment, K994119 Temporary Copings, K894844 ITI Protective Healing Caps, K962023, K051717 RN synOcta® Gold Copings for Bridges, K022859 RN synOcta® Gold Copings for Bars, K894844 RN synOcta® Titanium Copings for Bars, K990342 #### 4. Description of the Device The Straumann P.004 Dental Implant System is an integrated system of endosseous dental implants, which are designed to support prosthetic devices for partially or fully edentulous patients. The system consists of a variety of dental implants, abutments and surgical and prosthetic parts and instruments. Abutments are placed into dental implants to provide support for prosthetic restorations, copings for bars and bridges are used as a base for bar and bridge constructions, temporary copings support a temporary restoration out of occlusion and protective caps protect the abutment during the healing phase. {1}------------------------------------------------ K0801239 \$\underline{2^{c'i^2}}\$ #### 5. Intended Use of the Device Abutments are placed into dental implants to provide support for prosthetic restorations such as crowns, bridges and overdentures, Abutments can be used in single tooth replacements and multiple tooth restorations. The subject abutments are for permanent screw-retained bridges and bar-retained implant-borne dentures. Permanent copings are intended to serve as a base for multi-unit bar or bridge restorations. Temporary Copings are intended to serve as a base for temporary restorations for up to 6 month. Protective Caps are intended to protect the outer configuration of the abutment and to maintain and condition the contours of the soft tissue during the healing phase for up to 6 months. #### 6. Technological Characteristics The proposed Bar and Bridge Abutments, Permanent and Temporary Copings and Protective Caps are substantially equivalent to the currently cleared devices. The intended use is identical to the predicate devices. The proposed devices have the same material composition, basic design and fundamental operating principles to the currently cleared devices. 510(k) Submission: RC/NC Bar/Bridge Abutment Line January 30, 2008 {2}------------------------------------------------ DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread, symbolizing the department's mission to protect the health of all Americans. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 APR 3 0 2008 Ms. Elaine Alan Regulatory Affairs Specialist Straumann USA 60 Minuteman Road Andover, Massachusetts 01810 Re: K080239 Trade/Device Name: P.004 RC/NC Bar and Bridge Abutment Line P.004 Abutments P.004 Protective Caps P.004 Permanent Bar and Bridge Copings P.004 Temporary Copings Regulation Number: 21 CFR 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: II Product Code: NHA Dated: April 11, 2008 Received: April 21, 2008 Dear Ms. Alan: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ ### Page 2 - Ms. Alan Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Syrite Y. Michael md. Chiu Lin. Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ K080239 **INDICATIONS FOR USE STATEMENT** ## Device Name: P.004 Abutments Indications for Use: Abutments are intended to be placed into dental implants to provide support for prosthetic reconstructions such as crowns, bridges and overdentures. The subject abutments are for permanent screw-retained bridges and bar-retained implant-borne dentures. Device Name: P.004 Protective Caps Indications for Use: Protective Caps are intended to protect the outer configuration of the abutment and to maintain and condition the contours of the soft tissue during the healing phase for up to 6 months. Device Name: P.004 Permanent Bar and Bridge Copings Indications for Use: Copings are intended to serve as a base for multi-unit bar or bridge restorations. Device Name: P.004 Temporary Copings Indications for Use: Temporary Copings are intended to serve as a base for temporary restorations for up to 6 months. × Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 807 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) | | Concurrence of CDRH, Office of Device Evaluation (ODE) | | |--|--------------------------------------------------------|--| |--|--------------------------------------------------------|--| | |
(Division Sign-Off)
Division of Anesthesiology, General Hospital
Infection Control, Dental Devices
| (Division Sign-Off) | Division of Anesthesiology, General Hospital | Infection Control, Dental Devices | | |----------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------|----------------------------------------------|-----------------------------------|--| | (Division Sign-Off) | | | | | | | Division of Anesthesiology, General Hospital | | | | | | | Infection Control, Dental Devices | | | | | | | Page 1 of 1 | |---------------------------------------------------| | 510(k) Submission: RC/NC Bar/Bridge Abutment Line | | January 30, 2008 | | 510(k) Number: | K080239 | |----------------|---------| |----------------|---------| | | Straumann US Page 5 | |--|---------------------------------| |--|---------------------------------| --- **Source:** [https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/NHA/K080239](https://fda.innolitics.com/submissions/DE/subpart-d%E2%80%94prosthetic-devices/NHA/K080239) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com